Inspire Medical Systems, Inc.

Inspire Medical Systems, Inc., a self-certified small disadvantaged business, manufactures FDA-approved implantable neurostimulation devices for obstructive sleep apnea treatment and sells them to the Department of Veterans Affairs and Defense Health Agency as a prime contractor under GSA Medical Equipment and Supplies schedules (FSS-65-II-A).

Inspire is headquartered in Golden Valley, Minnesota, and operates as a for-profit corporation focused on a single product line: the INSPIRE Sleep Apnea System, an implantable upper airway stimulation device providing mask-free treatment for moderate to severe obstructive sleep apnea. The company manufactures implantable pulse generators, stimulation leads, respiratory sensing leads, sleep remote controls, and related implant components. Inspire competes in full-and-open procurements—no set-asides characterize its prime footprint—and delivers devices to federal healthcare agencies through firm fixed-price delivery orders and purchase orders, typically valued between $18,000 and $150,000 per order.

Federal engagement is concentrated overwhelmingly in the Veterans Health Administration. The VA accounts for approximately 90% of combined potential value across Inspire's federal footprint. Within the VA, Veterans Integrated Service Network 12 dominates dollars, carrying $107.4 million in combined potential value across 116 awards—a magnitude driven by a single large indefinite delivery vehicle. VISN 10 places the highest volume: 464 awards valued at $11.2 million. VISN 16 contributes 132 awards for $3.3 million, VISN 4 provides 93 awards for $2.4 million, and VISN 5 supplies 81 awards for $2.1 million. Outside the VA, the Defense Health Agency accounts for 49 awards and $5.1 million in combined potential value under a $2 million blanket purchase agreement (BPA) running through February 2026.

Inspire holds a single, agency-wide parent vehicle: the VA's Medical Equipment and Supplies Federal Supply Schedule (FSS-65-II-A), from which 943 task orders have been issued, carrying $30.4 million in combined potential value. The company does not appear on other government-wide acquisition contracts, agency IDIQs, or schedule vehicles beyond the VA medical equipment supply schedule and the Defense Health Agency BPA.

Award trajectory shows consistent federal engagement over the past five years, with 199 awards in 2022, declining to 83 in 2023, recovering to 137 in 2024, stabilizing at 139 in 2025, and reaching 123 through mid-October 2026. Recent activity is heavy: the source captures 1,292 prime awards since 2014, with the most recent award dated October 13, 2026. Combined potential value across all awards totals $144.4 million; obligated dollars stand at $36.8 million (25% draw-down). Twenty-nine awards face ultimate completion within the next twenty-four months, carrying $2 million in combined potential value—modest recompete exposure relative to the installed base.

Inspire operates as 100% prime (1,292 awards), with no subcontract footprint in the source. The company manufactures devices in-house at facilities in Golden Valley, Minnesota; Maple Grove, Minnesota; Minneapolis, Minnesota; Pittsburgh, Pennsylvania; Aspinwall, Pennsylvania; and Sharpsburg, Pennsylvania, with work performed at VA regional networks and Defense Health Agency locations nationwide.

Primary NAICS classification is 334517 (Electromedical and Electrotherapeutic Apparatus Manufacturing), capturing 1,061 of the company's 1,292 awards. Secondary NAICS include 339113 (Surgical Appliance and Supplies Manufacturing, 170 awards) and 339112 (Surgical and Medical Instrument Manufacturing, 58 awards). PSC coding is dominated by Medical And Surgical Instruments, Equipment, And Supplies (1,270 awards).

Inspire Medical Systems operates as a specialized medical device supplier to federal healthcare, with a narrow, clinical product focus and deep penetration in VA procurement across multiple regional networks. The company has no teaming partnerships, no subcontractor relationships, and no footprint on vehicles outside healthcare acquisition channels.